• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多塞平作为美沙酮维持治疗的抑郁患者的辅助疗法:一项双盲研究。

Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.

作者信息

Titievsky J, Seco G, Barranco M, Kyle E M

出版信息

J Clin Psychiatry. 1982 Nov;43(11):454-6.

PMID:7174622
Abstract

Depression and anxiety can contribute to both drug dependence and reduced retention rates in methadone maintenance programs. In a 5-week double-blind study, the effectiveness of doxepin as an adjunctive treatment was compared to placebo in 46 depressed/anxious patients attending a methadone maintenance program. Doxepin was superior to placebo on Clinical Global Impressions and several factors of the Hamilton Rating Scale for Depression and the Profile of Mood States. No clinically significant potentiation of side effects was observed with the combined administration of doxepin and methadone.

摘要

抑郁和焦虑会导致药物依赖,并降低美沙酮维持治疗项目中的留存率。在一项为期5周的双盲研究中,将多塞平作为辅助治疗的有效性与安慰剂在46名参加美沙酮维持治疗项目的抑郁/焦虑患者中进行了比较。在临床总体印象以及汉密尔顿抑郁评定量表和情绪状态剖面图的几个因素方面,多塞平优于安慰剂。多塞平和美沙酮联合使用未观察到临床上显著的副作用增强。

相似文献

1
Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.多塞平作为美沙酮维持治疗的抑郁患者的辅助疗法:一项双盲研究。
J Clin Psychiatry. 1982 Nov;43(11):454-6.
2
Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.多塞平与安非他酮治疗重度抑郁症门诊患者的双盲对照研究
J Clin Psychopharmacol. 1986 Feb;6(1):27-32.
3
A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients.三甲丙咪嗪和多塞平对住院抑郁症患者抗抑郁、抗焦虑及心血管作用的比较试验。
J Clin Psychiatry. 1985 Mar;46(3):90-4.
4
Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.氟西汀与多塞平治疗老年重度抑郁症的双盲对照试验。
J Clin Psychiatry. 1985 Mar;46(3 Pt 2):20-5.
5
Therapeutic superiority of maprotiline versus doxepin in geriatric depression.麦普替林与多塞平治疗老年抑郁症的疗效比较
J Clin Psychiatry. 1983 Dec;44(12):449-53.
6
Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.多塞平与阿米替林治疗重度抑郁症的多中心、安慰剂对照试验结果。普罗替林协作研究组。
J Clin Psychiatry. 1994 Jun;55(6):258-63.
7
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.两项关于帕罗西汀和多塞平治疗老年重度抑郁症患者的联合多中心双盲研究。
J Clin Psychiatry. 1992 Feb;53 Suppl:57-60.
8
Doxepin's effects on chronic pain and depression: a controlled study.多塞平对慢性疼痛和抑郁的影响:一项对照研究。
J Clin Psychiatry. 1984 Mar;45(3 Pt 2):47-53.
9
Onset of action of amoxapine and doxepin in outpatients with "mixed anxiety/depression".阿莫沙平和多塞平在“混合性焦虑/抑郁”门诊患者中的起效情况。
J Clin Psychiatry. 1983 Jul;44(7):248-52.
10
Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone.海洛因成瘾者的抑郁和焦虑:多塞平联合美沙酮的安慰剂对照研究
Am J Psychiatry. 1975 Apr;132(4):447-50. doi: 10.1176/ajp.132.4.447.

引用本文的文献

1
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.治疗阿片类药物使用障碍患者的抑郁轨迹:XBOT 试验的增长混合模型二次分析。
Am J Addict. 2023 May;32(3):291-300. doi: 10.1111/ajad.13371. Epub 2023 Jan 16.
2
Stress, craving and mood as predictors of early dropout from opioid agonist therapy.压力、渴求感和情绪对阿片类激动剂治疗早期脱落的预测作用。
Drug Alcohol Depend. 2019 Sep 1;202:200-208. doi: 10.1016/j.drugalcdep.2019.05.026. Epub 2019 Jul 16.
3
Treatment of substance abusing patients with comorbid psychiatric disorders.
治疗伴有精神障碍的物质滥用患者。
Addict Behav. 2012 Jan;37(1):11-24. doi: 10.1016/j.addbeh.2011.09.010. Epub 2011 Sep 14.
4
Treating depression in substance abusers.治疗药物滥用者的抑郁症。
Curr Psychiatry Rep. 2006 Oct;8(5):363-70. doi: 10.1007/s11920-006-0037-8.